Michael S. Brown
Director at Regeneron Pharmaceuticals. Based in Tarrytown, New York.
- Rank
- 7716th of 14,644
- Companies held
- 1
- Largest holding
- REGN, 100.0% of total
- Latest SEC filing
- Oct 30, 2026
What the $11.9M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Regeneron Pharmaceuticals REGN Common Stock | Through Trust | 6,485 | $923.34 | $6.0M | 50.4% | Form 4, Oct 30, 2026 |
| Regeneron Pharmaceuticals REGN Common Stock | Through SLAT | 5,000 | $923.34 | $4.6M | 38.9% | Form 4, Oct 30, 2026 |
| Regeneron Pharmaceuticals REGN Common Stock | Directly | 1,380 | $923.34 | $1.3M | 10.7% | Form 4, Oct 30, 2026 |
Share counts are the amounts Michael S. Brown reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 7713 | Toni Townes-Whitley Chief Executive Officer, Science Applications International. New York, NY | $11.9M |
| 7714 | David Boulette Chief Executive Officer, Eva Live. Las Vegas, NV | $11.9M |
| 7715 | Neena M. Patil EVP & Chief Legal Officer, Jazz Pharmaceuticals | $11.9M |
| 7716 | Michael S. Brown Director, Regeneron Pharmaceuticals. Tarrytown, NY | $11.9M |
| 7717 | Braden M Leonard 10% owner, Enliven Therapeutics. Zionsville, IN | $11.9M |
| 7718 | Mayur Kapani Chief Technology Officer, Intercontinental Exchange. Atlanta, GA | $11.9M |
| 7719 | Mark J. Silk Director, SIFCO Industries. Cleveland, OH | $11.9M |
Other Regeneron Pharmaceuticals insiders
All REGN insiders- Leonard S. Schleifer$2.21BBd. Co-Chair, President & CEO. #141 overall
- George Yancopoulos$855MBd. Co-Chair, President & CSO. #312 overall
- P. Roy Vagelos$431MDirector. #529 overall
- Neil E. Stahl$54.7MEVP Research and Development. #2374 overall
- Andrew Murphy$47.3MCo-Chief Scientific Officer. #2647 overall
- Joseph LaRosa$44.4MEVP General Counsel and Secret. #2766 overall
Questions
How much stock does Michael S. Brown own?
Michael S. Brown holds $11,878,769 in listed stock based on SEC filings and current prices, mostly Regeneron Pharmaceuticals (REGN). That ranks 7716th on the Stock Rich List.
Is this Michael S. Brown's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Michael S. Brown last buy or sell stock?
The most recent open-market trade on file is a sale of 1,929 REGN shares on Oct 30, 2026 at $875.00.